Code | 6257D | ||||||||||
MA number | 21/0292/20-S | ||||||||||
Product Form: | tbl flm 50x1000 mg (blis.Al/PVC/PE/PVDC) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister Al/PVC/PE/PVDC | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 23.12.2020 |
Validity: | 23.12.2025 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Levetiracetam Stada Arzneimittel_12.2021.pdf |
PIL: | PIL_Levetiracetam Stada Arzneimittel_04.2024.pdf |
Safety feature | Yes |
Data update: | 19.03.2021 |